HomeInsights52 Week High Stocks

Gland Pharma Ltd 52 Week High

Gland Pharma Ltd 52 Week High

stocks purchased

₹ 15.5 Cr

Volume transacted

stocks purchased

85.7 K

stocks traded

Last Updated time: 05 Nov 14:02 PM

Image

Gland Pharma Ltd

NSE: GLAND

YEARHIGH

2220.95

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week HIGH of Gland Pharma Ltd is ₹ 2220 as of 04 Nov 24.

Company Fundamentals for Gland Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241609.85
01 Nov 20241644.85
31 Oct 20241650.85
30 Oct 20241643.05
29 Oct 20241625.35
28 Oct 20241625.1
25 Oct 20241606.15
24 Oct 20241640.9
23 Oct 20241610.15
22 Oct 20241647.1

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Gland Pharma Ltd News Hub

News

Gland Pharma soars as Q2 PAT rises 9% YoY to Rs 282 cr

On consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore on 2.36% t...

Read more

05 Nov 202410:42

News

Volumes jump at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Hatsun Agro Product Ltd, ABB India Ltd, Bata India Ltd are among the...

Read more

05 Nov 202411:00

News

Gland Pharma to hold board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 4 November 20...

Read more

23 Oct 202410:19

News

Gland Pharma Ltd slips for fifth straight session

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 18...

Read more

19 Sep 202413:35

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

07 Aug 202411:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Gland Pharma Ltd

What is the significance of Gland Pharma Ltd reaching its 52-week high?

Gland Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Gland Pharma Ltd 52-week high?

Investors monitor Gland Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Gland Pharma Ltd a good buy when it hits its 52-week high?

Whether Gland Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Gland Pharma Ltd fundamentals.

What should I consider before investing in Gland Pharma Ltd at its 52-week high?

Before investing in Gland Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Gland Pharma Ltd stock price continue to rise after reaching its 52-week high?

Gland Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*